Varian Medical Systems, Inc. (NYSE:VAR) is reporting fourth quarter financial results on Tuesday 27th October 2020, after market close.
According to analysts surveyed by Thomson Reuters, VAR is expected to report 4Q20 income of $ 1.02 per share from revenue of $ 812.96 million.
For the full year, analysts anticipate top line of $ 3125.51 million, while looking forward to income of $ 3.76 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 3,451.00 million ~ $ 3,515.00 million, where as bottomline are predicted in a range of $ 5.30 ~ $ 5.45 per share
Click Here For More Historical Outlooks Of Varian Medical Systems, Inc.
Previous Quarter Performance
Varian Medical Systems, Inc. came out with income for the third quarter of $ 0.78 per share, from the revenue of $ 694.30 million. Street analysts expected Varian Medical Systems, Inc. to report income of $ 0.52 per share on revenue of $ 664.38 million for the third quarter. The bottom line results beat street analysts by $ 0.26 or 50.00 percent, at the same time, top line results outshined analysts by $ 29.92 million or 4.50 percent.
Stock Performance
Shares of Varian Medical Systems, Inc. traded up $ 0.83 or 0.48 percent on Friday, reaching $ 172.56 with volume of 1.65 million shares. Varian Medical Systems, Inc. has traded high as $ 173.50 and has cracked $ 172.35 on the downward trend
According to the previous trading day, closing price of $ 172.56, representing a 91.62 % increase from the 52 week low of $ 89.62 and a 2.53 % decrease over the 52 week high of $ 176.19.
The company has a market capital of $ 15.73 billion and is part of the Healthcare sector and Medical Instruments & Supplies industry.
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions.
